XML 41 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
AXT, Inc. Stockholders' Equity
Noncontrolling Interests
Total
Balance, beginning of period at Dec. 31, 2020 $ 3,532 $ 42 $ 230,381 $ (44,545) $ 3,209 $ 192,619 $ 15,350 $ 207,969
Balance (in shares) at Dec. 31, 2020 883 41,967            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock options exercised   $ 1 1,669     1,670   1,670
Common stock options exercised (in shares)   507            
Formation of new subsidiary with noncontrolling interests     (262)     (262) 1,413 1,151
Transfer of subsidiary with noncontrolling interests     (1,229)     (1,229) 1,229  
Restricted stock awards canceled   (14)            
Stock-based compensation     4,519     4,519   4,519
Issuance of common stock in the form of restricted stock (in shares)   426            
Purchase of subsidiary shares from noncontrolling interests     (2,691)     (2,691) (1,039) (3,730)
Transfer of subsidiary with redeemable noncontrolling interest     (1,241)     (1,241)   (1,241)
Noncontrolling interest portion of Tongmei stock-based compensation     (62)     (62) 40 (22)
Sale of common stock to employees in connection with the reorganization     538     538   538
Net income (loss)       14,575   14,575 1,045 15,620
Other comprehensive income (loss)         3,093 3,093 279 3,372
Balance, end of period at Dec. 31, 2021 $ 3,532 $ 43 231,622 (29,970) 6,302 211,529 18,317 229,846
Balance (in shares) at Dec. 31, 2021 883 42,886            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock options exercised   $ 1 517     518   518
Common stock options exercised (in shares)   172            
Restricted stock awards canceled   (91)            
Stock-based compensation     3,273     3,273   3,273
Issuance of common stock in the form of restricted stock (in shares)   587            
Purchase of subsidiary shares from noncontrolling interests     (466)     (466) 2,699 2,233
Noncontrolling interest portion of Tongmei stock-based compensation     100     100 (42) 58
Net income (loss)       15,811   15,811 1,333 17,144
Other comprehensive income (loss)         (9,420) (9,420) (901) (10,321)
Investment in subsidiary from noncontrolling interest             1,887 1,887
Investment in subsidiary with redeemable noncontrolling interest     (471)     (471)   (471)
Tongmei stock-based compensation     733     733   733
Balance, end of period at Dec. 31, 2022 $ 3,532 $ 44 235,308 (14,159) (3,118) 221,607 23,293 244,900
Balance (in shares) at Dec. 31, 2022 883 43,554            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock options exercised     10     10   10
Common stock options exercised (in shares)   4            
Restricted stock awards canceled   (23)            
Stock-based compensation     2,779     2,779   2,779
Issuance of common stock in the form of restricted stock (in shares)   704            
Purchase of subsidiary shares from noncontrolling interests     (153)     (153) 861 708
Noncontrolling interest portion of Tongmei stock-based compensation     (98)     (98) 55 (43)
Net income (loss)       (17,881)   (17,881) (391) (18,272)
Other comprehensive income (loss)         (2,881) (2,881) (324) (3,205)
Investment in subsidiary with redeemable noncontrolling interest     (155)     (155)   (155)
Tongmei stock-based compensation     761     761   761
Balance, end of period at Dec. 31, 2023 $ 3,532 $ 44 $ 238,452 $ (32,040) $ (5,999) $ 203,989 $ 23,494 $ 227,483
Balance (in shares) at Dec. 31, 2023 883 44,239